These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27377320)

  • 1. Epigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells.
    He K; Qu H; Xu LN; Gao J; Cheng FY; Xiang P; Zhou CQ
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27377320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer.
    Dai F; Zhang Y; Zhu X; Shan N; Chen Y
    Gynecol Oncol; 2013 Nov; 131(2):451-9. PubMed ID: 23933187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant adenovirus-mediated overexpression of PTEN and KRT10 improves cisplatin resistance of ovarian cancer in vitro and in vivo.
    Wu H; Wang K; Liu W; Hao Q
    Genet Mol Res; 2015 Jun; 14(2):6591-7. PubMed ID: 26125866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
    Lee S; Choi EJ; Jin C; Kim DH
    Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
    Yan X; Fraser M; Qiu Q; Tsang BK
    Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
    Liu YL; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2.
    Li J; Jiang K; Zhao F
    Oncol Rep; 2015 Jun; 33(6):2829-36. PubMed ID: 25845681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN overexpression improves cisplatin-resistance of human ovarian cancer cells through upregulating KRT10 expression.
    Wu H; Wang K; Liu W; Hao Q
    Biochem Biophys Res Commun; 2014 Feb; 444(2):141-6. PubMed ID: 24434152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3].
    Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of LfcinB9 on human ovarian cancer cell SK-OV-3 is mediated by inducing apoptosis.
    Sheng M; Zhao Y; Zhang A; Wang L; Zhang G
    J Pept Sci; 2014 Oct; 20(10):803-10. PubMed ID: 24965354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].
    Jiang WY; Kang JL; Wang XX; Yang WJ; Nie ML; Zhou C
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):778-83. PubMed ID: 24406137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reversal of drug resistance in human ovarian cancer cells by wild-type PTEN gene and its mechanisms].
    Wu HJ; Wu HT; Weng DH; Xing H; Lu YP; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):612-6. PubMed ID: 17983517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAT-OSBP-1-MKK6(E), a novel TAT-fusion protein with high selectivity for human ovarian cancer, exhibits anti-tumor activity.
    Zhong J; Kang J; Wang X; Jiang W; Liao H; Yuan J
    Med Oncol; 2015 Apr; 32(4):118. PubMed ID: 25782870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis.
    Li Y; Xiao M; Guo F
    Tumour Biol; 2017 May; 39(5):1010428317705508. PubMed ID: 28475012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells.
    Melzer C; von der Ohe J; Hass R
    Cell Commun Signal; 2018 Oct; 16(1):67. PubMed ID: 30316300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrotic cell death of ovarian adenocarcinoma caused by seminal plasma.
    Park LO; Yoon JH; Kim JD; Seo JT; Bae SN
    Gynecol Oncol; 2004 Jun; 93(3):671-9. PubMed ID: 15196863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of transgenic human embryonic stem cell line BJNhem20-OCIAD1-OV.
    Shetty DK; Inamdar MS
    Stem Cell Res; 2016 Jan; 16(1):192-4. PubMed ID: 27345812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
    Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
    Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
    Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
    Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral cancer/endothelial cell fusion experiences nuclear fusion and acquisition of enhanced survival potential.
    Song K; Song Y; Zhao XP; Shen H; Wang M; Yan TL; Liu K; Shang ZJ
    Exp Cell Res; 2014 Oct; 328(1):156-163. PubMed ID: 25016285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.